LARS anticorps (AA 614-892) (FITC)

N° du produit ABIN7158036

Détail du produit anti-LARS anticorps (FITC)

Antigène: LARS (Leucyl-tRNA Synthetase (LARS))

Épitope: AA 614-892

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LARS est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Leucine--tRNA ligase, cytoplasmic protein (614-892AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur LARS

Antigène: LARS (Leucyl-tRNA Synthetase (LARS))

Autre désignation: LARS (LARS Produits)

Synonymes: anticorps HSPC192, anticorps LARS1, anticorps LEURS, anticorps LEUS, anticorps LRS, anticorps PIG44, anticorps RNTLS, anticorps hr025Cl, anticorps CG7479, anticorps Dmel\\CG7479, anticorps LeuRS, anticorps F21M12.1, anticorps F21M12_1, anticorps BA4991, anticorps DDBDRAFT_0183834, anticorps DDBDRAFT_0231251, anticorps DDB_0183834, anticorps DDB_0231251, anticorps 2310045K21Rik, anticorps 3110009L02Rik, anticorps AW536573, anticorps mKIAA1352, anticorps leucyl-tRNA synthetase, anticorps Leucyl-tRNA synthetase, mitochondrial, anticorps ATP binding/leucine-tRNA ligases/aminoacyl-tRNA ligase, anticorps leucine--tRNA ligase, anticorps leucyl-tRNA synthetase LeuS, anticorps leucyl-tRNA ligase, anticorps leucine-tRNA ligase, anticorps LARS, anticorps LeuRS-m, anticorps AT1G09620, anticorps leuS, anticorps APH_RS02290, anticorps mleuS, anticorps Lars

Sujet:

Background: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs.

Aliases: cytoplasmic antibody, Cytoplasmic leucyl tRNA synthetase antibody, Cytosolic leucyl tRNA synthetase antibody, FLJ10595 antibody, FLJ21788 antibody, hr025Cl antibody, HSPC 192 antibody, HSPC192 antibody, KIAA1352 antibody, LARS 1 antibody, Lars antibody, LARS1 antibody, Leucine translase antibody, Leucine tRNA ligase antibody, Leucine--tRNA ligase antibody, Leucyl tRNA synthetase cytoplasmic antibody, Leucyl-tRNA synthetase antibody, LeuRS antibody, LEUS antibody, LRS antibody, PIG 44 antibody, PIG44 antibody, Proliferation inducing gene 44 antibody, RNTLS antibody, SYLC_HUMAN antibody

UniProt: Q9P2J5

Pathways: EGFR Signaling Pathway